GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Beneish M-Score

Genesystem Co (XKRX:363250) Beneish M-Score : -5.18 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -5.18 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Genesystem Co's Beneish M-Score or its related term are showing as below:

XKRX:363250' s Beneish M-Score Range Over the Past 10 Years
Min: -5.18   Med: -2.05   Max: 2.38
Current: -5.18

During the past 5 years, the highest Beneish M-Score of Genesystem Co was 2.38. The lowest was -5.18. And the median was -2.05.


Genesystem Co Beneish M-Score Historical Data

The historical data trend for Genesystem Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Beneish M-Score Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - - -2.94 -3.35

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.63 2.38 1.97 -3.35 -5.18

Competitive Comparison of Genesystem Co's Beneish M-Score

For the Diagnostics & Research subindustry, Genesystem Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genesystem Co's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Genesystem Co's Beneish M-Score falls into.



Genesystem Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Genesystem Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0+0.528 * 0.046+0.404 * 3.9842+0.892 * 0.2557+0.115 * 0.0627
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 10.6154+4.679 * -0.04713-0.327 * 0.5073
=-5.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₩0.0 Mil.
Revenue was 135.21 + 66.265 + 203.981 + 153.994 = ₩559.5 Mil.
Gross Profit was -189.745 + -657.601 + -372.528 + -293.708 = ₩-1,513.6 Mil.
Total Current Assets was ₩18,768.9 Mil.
Total Assets was ₩36,583.1 Mil.
Property, Plant and Equipment(Net PPE) was ₩0.0 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩444.5 Mil.
Selling, General, & Admin. Expense(SGA) was ₩3,028.2 Mil.
Total Current Liabilities was ₩2,413.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₩0.0 Mil.
Net Income was -2173.647 + -1496.695 + -2283.822 + -1952.449 = ₩-7,906.6 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0.0 Mil.
Cash Flow from Operations was 0 + -2177.026 + -1695.034 + -2310.384 = ₩-6,182.4 Mil.
Total Receivables was ₩902.4 Mil.
Revenue was 472.788 + 735.714 + 496.173 + 483.209 = ₩2,187.9 Mil.
Gross Profit was -262.243 + 23.757 + -25.876 + -8.144 = ₩-272.5 Mil.
Total Current Assets was ₩28,472.5 Mil.
Total Assets was ₩39,216.9 Mil.
Property, Plant and Equipment(Net PPE) was ₩5,951.3 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩397.9 Mil.
Selling, General, & Admin. Expense(SGA) was ₩1,115.6 Mil.
Total Current Liabilities was ₩2,025.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₩3,074.3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0 / 559.45) / (902.356 / 2187.884)
=0 / 0.412433
=0

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-272.506 / 2187.884) / (-1513.582 / 559.45)
=-0.124552 / -2.705482
=0.046

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (18768.863 + 0) / 36583.079) / (1 - (28472.456 + 5951.323) / 39216.929)
=0.486952 / 0.122221
=3.9842

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=559.45 / 2187.884
=0.2557

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(397.93 / (397.93 + 5951.323)) / (444.532 / (444.532 + 0))
=0.062674 / 1
=0.0627

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3028.226 / 559.45) / (1115.618 / 2187.884)
=5.412863 / 0.509907
=10.6154

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 2413.305) / 36583.079) / ((3074.256 + 2025.336) / 39216.929)
=0.065968 / 0.130035
=0.5073

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-7906.613 - 0 - -6182.444) / 36583.079
=-0.04713

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Genesystem Co has a M-score of -5.18 suggests that the company is unlikely to be a manipulator.


Genesystem Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines